Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Chemotherapy-induced sclerosing cholangitis (or biliary sclerosis)
Iatrogenic cholangitis following intraarterial chemotherapy for hepatic malignancies
MR with MRCP is best imaging test
Segmental strictures of variable length (similar to those seen in primary sclerosing cholangitis)
Strictures of common hepatic and larger intrahepatic ducts
Frequently involves common hepatic duct and biliary confluence but not common bile duct
Ductal abnormalities may include
Duct wall thickening and luminal narrowing
Dilation of intrahepatic bile ducts upstream from strictures
Periductal edema
Hepatic perfusion abnormalities
CT or MR may be necessary to differentiate cholangitis from extrinsic duct compression by lymph nodes or tumor
Primary sclerosing cholangitis
Autoimmune pancreatitis-cholangitis syndrome
Extrinsic compression (liver masses)
Chemical hepatitis
Cholangiographic abnormalities reported in 7-30% of patients undergoing intraarterial chemotherapy
Severe complications
Acute or subacute hepatic failure or death
Treatment
Immediate cessation of intraarterial floxuridine; surgical or percutaneous drainage of biliary tree; endoscopic balloon dilation of stricture ± stenting
Chemotherapy-induced sclerosing cholangitis (CISC): Biliary sclerosis
Iatrogenic cholangitis following intraarterial chemotherapy for hepatic malignancies or metastases
Complication of hepatic artery infusion pump (HAIP) or transarterial chemoembolization (TACE)
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here